SK2 Protein
Overview
SK2 (Small conductance calcium-activated potassium channel subunit 2), encoded by the KCNN2 gene, is a voltage-independent ion channel that plays a critical role in regulating neuronal excitability and calcium signaling. As a member of the SK (small-conductance) potassium channel family, SK2 is activated by intracellular calcium and produces a delayed hyperpolarizing afterhyperpolarization (AHP) that follows action potentials. This family includes three main members (SK1, SK2, and SK3), with SK2 being particularly abundant in the central nervous system, particularly in hippocampal pyramidal neurons, cerebellar Purkinje cells, and cortical neurons. The protein forms functional channels as tetramers and couples calcium/calmodulin binding directly to potassium conductance without requiring additional voltage-sensing domains.
Function and Biology
SK2 channels function as calcium sensors that directly bind calmodulin in their C-terminal domain, coupling intracellular calcium concentration changes to potassium ion efflux. When calcium enters the cell through voltage-gated calcium channels during neuronal activity, it binds to calmodulin associated with SK2, triggering a conformational change that opens the channel pore. This potassium efflux hyperpolarizes the membrane potential, creating the AHP that limits neuronal firing frequency and regulates spike-timing dependent plasticity.
...SK2 Protein
Overview
SK2 (Small conductance calcium-activated potassium channel subunit 2), encoded by the KCNN2 gene, is a voltage-independent ion channel that plays a critical role in regulating neuronal excitability and calcium signaling. As a member of the SK (small-conductance) potassium channel family, SK2 is activated by intracellular calcium and produces a delayed hyperpolarizing afterhyperpolarization (AHP) that follows action potentials. This family includes three main members (SK1, SK2, and SK3), with SK2 being particularly abundant in the central nervous system, particularly in hippocampal pyramidal neurons, cerebellar Purkinje cells, and cortical neurons. The protein forms functional channels as tetramers and couples calcium/calmodulin binding directly to potassium conductance without requiring additional voltage-sensing domains.
Function and Biology
SK2 channels function as calcium sensors that directly bind calmodulin in their C-terminal domain, coupling intracellular calcium concentration changes to potassium ion efflux. When calcium enters the cell through voltage-gated calcium channels during neuronal activity, it binds to calmodulin associated with SK2, triggering a conformational change that opens the channel pore. This potassium efflux hyperpolarizes the membrane potential, creating the AHP that limits neuronal firing frequency and regulates spike-timing dependent plasticity.
The channel's regulation involves multiple phosphorylation sites. Protein kinase C (PKC) and other kinases can phosphorylate SK2, modulating its sensitivity to calcium and altering its contribution to AHP duration. Additionally, SK2 interacts with the scaffolding protein AKAP79/150 (A-kinase anchoring protein), positioning it near protein kinase A and other signaling enzymes, allowing coordinated regulation of channel function within localized cellular compartments.
SK2 channels are particularly enriched at synaptic sites and participate in synaptic plasticity mechanisms. Long-term potentiation (LTP) and long-term depression (LTD) involve dynamic regulation of SK2 activity, as the channel's modulation of AHP duration directly affects the temporal window for synaptic integration and plasticity induction. The channel also contributes to neuronal excitability homeostasis by preventing excessive firing rates and maintaining stable network oscillations.
Role in Neurodegeneration
SK2 dysfunction has emerged as a significant factor in multiple neurodegenerative diseases. In Alzheimer's disease, amyloid-beta (Aβ) peptides, particularly Aβ42, directly interact with and inhibit SK2 channels, leading to reduced potassium conductance and enhanced neuronal excitability. This Aβ-induced SK2 inhibition increases calcium influx through voltage-gated calcium channels and contributes to excitotoxicity, a hallmark of Alzheimer's pathology. Studies demonstrate that restoring SK2 function ameliorates Aβ-induced neuronal damage.
In Parkinson's disease, altered SK2 expression and function have been observed in substantia nigra dopaminergic neurons, potentially contributing to the selective vulnerability of these cells. The loss of dopamine signaling may impair SK2 regulation through PKA-mediated phosphorylation, disrupting calcium homeostasis and increasing oxidative stress.
Huntington's disease involves expanded polyglutamine repeats in the huntingtin protein, which impairs SK2 channel trafficking and reduces surface expression in striatal neurons. This dysfunction contributes to enhanced excitotoxicity and striatal cell death characteristic of the disease. Additionally, SK2 has been implicated in amyotrophic lateral sclerosis (ALS) pathology, where altered SK2 function in motor neurons may compromise calcium buffering capacity and increase vulnerability to excitotoxic damage.
Molecular Mechanisms
The neurotoxic mechanisms involving SK2 dysfunction center on calcium dysregulation. By reducing SK2-mediated potassium conductance, pathogenic insults increase neuronal excitability and calcium influx, overwhelming cellular calcium buffering systems. This leads to mitochondrial calcium overload, reactive oxygen species generation, and activation of calcium-dependent proteases like calpains. Reduced SK2 activity also impairs activity-dependent neuroprotection and synaptic plasticity mechanisms essential for neuronal survival.
Aberrant SK2 phosphorylation states and altered association with AKAP79/150 have been documented in disease contexts, suggesting impaired coupling between kinase signaling cascades and channel function.
Clinical and Research Significance
SK2 activators, particularly compounds like 1-EBIO and others targeting the channel's calcium-binding domain, represent promising therapeutic candidates for neurodegenerative diseases. These agents enhance SK2-mediated hyperpolarization, reduce excitotoxicity, and promote neuroprotection in disease models. Several research initiatives are exploring selective SK2 modulators as disease-modifying therapeutics.
- KCNN2 gene
- SK1 and SK3 proteins
- Calmodulin
- Amyloid-beta
- Neuronal excitability
- Calcium homeostasis
- Long-term potentiation